Get the Stockscreener App
2.00
18.34%
0.31
After Hours:
2.00
China Sxt Pharmaceuticals Inc Stock (SXTC) Forecast
The China Sxt Pharmaceuticals Inc (SXTC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5,581.70, representing a +278.98K% increase from the current price of $2.00. The highest analyst price target is $5,627.71, and the lowest is $5,535.69.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SXTC Price Target
Average 4,905.54
(+245.18K% Upside)
Is China Sxt Pharmaceuticals Inc (SXTC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 71.52 | Sell |
| STOCH(9,6) | 67.52 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0904 | Buy |
| ADX(14) | 45.27 | Buy |
| William %R | 0.00 | Sell |
| CCI(14) | 188.20 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.6242
Buy
|
1.6786
Buy
|
| MA20 |
1.5566
Buy
|
1.593
Buy
|
| MA50 |
1.4588
Buy
|
1.5222
Buy
|
| MA100 |
1.5205
Buy
|
1.5777
Buy
|
| MA200 |
1.6954
Buy
|
1.9943
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, SXTC could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 3 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on SXTC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 71.52 indicates that SXTC is overbought. This suggests that SXTC price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 67.52 indicates that SXTC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that SXTC is oversold. This suggests that SXTC price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 45.27 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 188.2 indicates that SXTC is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term SXTC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about China Sxt Pharmaceuticals Inc financial reports and earnings history, China Sxt Pharmaceuticals Inc (SXTC) stock could reach $10,649.83 by 2030, $5,976.86 by 2040 and $19,978.63 by 2050. See the projected annual prices until 2050 of the China Sxt Pharmaceuticals Inc stock below:
- China Sxt Pharmaceuticals Inc (SXTC) is expected to reach an average price of $1,717.89 in 2035, with a high prediction of $1,962.58 and a low estimate of $1,718.10. This indicates an $85,794% rise from the last recorded price of $2.00.
- China Sxt Pharmaceuticals Inc (SXTC) stock is projected to chart a bullish course in 2040, with an average price target of $5,702.10, representing an $285.00K% surge from its current level. The forecast ranges from a conservative $5,703.77 to a sky-high $5,976.86.
- Our analysts predict China Sxt Pharmaceuticals Inc (SXTC) to jump 581.93K% by 2045, soaring from $11,643.47 to an average price of $11,640.70, potentially reaching $11,998.53. While $11,643.47 is the low estimate, the potential upside is significant.
- China Sxt Pharmaceuticals Inc (SXTC) stock is expected to climb by 2050, reaching an average of $19,526.53, a $976.23K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $19,978.63 and $19,555.23, respectively, highlighting the market's uncertainty.
China Sxt Pharmaceuticals Inc Stock (SXTC) Year by Year Forecast
China Sxt Pharmaceuticals Inc Stock (SXTC) Price Forecast for 2026
The predicted value for China Sxt Pharmaceuticals Inc (SXTC) in 2026 is set at an average of $4,956.65. Estimates vary from a peak of $5,683.00 to a trough of $4,230.30, indicating an +247.73K% surge from the present price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $5,533.89 | $5,535.69 | $5,627.71 | +276.59K% |
| March, 2026 | $4,852.99 | $5,102.79 | $5,354.54 | +242.55K% |
| April, 2026 | $4,289.63 | $4,230.30 | $4,450.32 | +214.38K% |
| May, 2026 | $4,721.93 | $4,761.93 | $4,672.61 | +236.00K% |
| June, 2026 | $4,809.24 | $4,737.41 | $4,676.26 | +240.36K% |
| July, 2026 | $4,870.87 | $4,822.22 | $4,838.54 | +243.44K% |
| August, 2026 | $4,553.18 | $4,643.18 | $4,755.45 | +227.56K% |
| September, 2026 | $4,509.81 | $4,530.44 | $4,531.83 | +225.39K% |
| October, 2026 | $4,437.12 | $4,462.12 | $4,397.17 | +221.76K% |
| November, 2026 | $4,354.43 | $4,384.43 | $4,390.77 | +217.62K% |
| December, 2026 | $4,271.06 | $4,286.06 | $4,313.80 | +213.45K% |
China Sxt Pharmaceuticals Inc Stock (SXTC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for China Sxt Pharmaceuticals Inc (SXTC) is $3,697.59, with a high forecast of $4,240.39 and a low forecast of $3,154.80. This indicates an +184.78K% increase from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4,133.37 | $4,183.37 | $4,240.39 | +206.57K% |
| February, 2027 | $4,135.27 | $4,132.02 | $4,092.02 | +206.66K% |
| March, 2027 | $4,074.46 | $4,094.81 | $4,105.75 | +203.62K% |
| April, 2027 | $3,995.86 | $4,031.41 | $4,036.63 | +199.69K% |
| May, 2027 | $4,043.22 | $4,050.42 | $4,100.99 | +202.06K% |
| June, 2027 | $3,902.80 | $3,906.05 | $4,002.25 | +195.04K% |
| July, 2027 | $3,725.86 | $3,767.41 | $3,855.53 | +186.19K% |
| August, 2027 | $3,649.07 | $3,650.67 | $3,680.19 | +182.35K% |
| September, 2027 | $3,542.55 | $3,545.05 | $3,587.54 | +177.03K% |
| October, 2027 | $3,426.86 | $3,428.86 | $3,504.13 | +171.24K% |
| November, 2027 | $3,297.91 | $3,299.41 | $3,379.43 | +164.80K% |
| December, 2027 | $3,151.80 | $3,154.80 | $3,263.74 | +157.49K% |
China Sxt Pharmaceuticals Inc Stock (SXTC) Price Forecast for 2028
In 2028, China Sxt Pharmaceuticals Inc (SXTC) is projected to reach an average price of $2,354.94, with a high projection of $3,119.12 and a low estimate of $1,590.76. This indicates an +117.65K% rise from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3,038.35 | $3,038.85 | $3,119.12 | +151.82K% |
| February, 2028 | $2,926.41 | $2,929.89 | $3,008.18 | +146.22K% |
| March, 2028 | $2,777.29 | $2,777.29 | $2,891.49 | +138.76K% |
| April, 2028 | $2,654.45 | $2,655.34 | $2,745.37 | +132.62K% |
| May, 2028 | $2,503.23 | $2,504.46 | $2,620.18 | +125.06K% |
| June, 2028 | $2,377.97 | $2,379.29 | $2,469.81 | +118.80K% |
| July, 2028 | $2,258.09 | $2,258.58 | $2,346.62 | +112.80K% |
| August, 2028 | $2,109.91 | $2,110.22 | $2,225.17 | +105.40K% |
| September, 2028 | $1,989.00 | $1,989.16 | $2,079.06 | +99,350% |
| October, 2028 | $1,867.14 | $1,867.34 | $1,957.36 | +93,257% |
| November, 2028 | $1,713.03 | $1,713.81 | $1,833.20 | +85,552% |
| December, 2028 | $1,590.16 | $1,590.76 | $1,681.55 | +79,408% |
China Sxt Pharmaceuticals Inc Stock (SXTC) Price Forecast for 2029
The 2029 price forecast for China Sxt Pharmaceuticals Inc Stock (SXTC) is $4,044.33 on average, with a high prediction of $8,057.96 and a low estimate of $30.69. This represents an +202.12K% increase from the previous price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1,437.57 | $1,437.92 | $1,559.13 | +71,778% |
| February, 2029 | $1,316.84 | $1,316.97 | $1,406.11 | +65,742% |
| March, 2029 | $1,193.99 | $1,194.50 | $1,285.95 | +59,599% |
| April, 2029 | $1,071.64 | $1,072.25 | $1,162.23 | +53,482% |
| May, 2029 | $919.27 | $919.36 | $1,040.37 | +45,863% |
| June, 2029 | $795.92 | $796.49 | $887.90 | +39,696% |
| July, 2029 | $671.86 | $673.95 | $765.18 | +33,493% |
| August, 2029 | $520.53 | $520.75 | $642.09 | +25,926% |
| September, 2029 | $397.96 | $398.01 | $489.68 | +19,798% |
| October, 2029 | $244.62 | $244.81 | $367.02 | +12,131% |
| November, 2029 | $122.69 | $122.77 | $213.90 | +6,035% |
| December, 2029 | $9,017.96 | $30.69 | $8,057.96 | +450.80K% |
China Sxt Pharmaceuticals Inc Stock (SXTC) Price Forecast for 2030
China Sxt Pharmaceuticals Inc Stock (SXTC) is expected to reach an average price of $12,111.70 in 2030, with a high forecast of $14,249.48 and a low forecast of $9,973.92. This signifies an +605.48K% surge from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11,451.23 | $9,973.92 | $10,649.83 | +572.46K% |
| February, 2030 | $11,605.84 | $11,317.13 | $10,925.84 | +580.19K% |
| March, 2030 | $12,740.45 | $11,820.69 | $12,060.45 | +636.92K% |
| April, 2030 | $12,095.07 | $12,061.01 | $12,439.11 | +604.65K% |
| May, 2030 | $14,168.33 | $12,552.37 | $13,888.33 | +708.32K% |
| June, 2030 | $14,322.95 | $14,402.95 | $14,102.95 | +716.05K% |
| July, 2030 | $14,436.71 | $14,040.25 | $14,156.21 | +721.74K% |
| August, 2030 | $14,490.23 | $14,374.87 | $14,193.52 | +724.41K% |
| September, 2030 | $13,505.44 | $14,165.44 | $14,249.48 | +675.17K% |
| October, 2030 | $13,589.11 | $13,558.05 | $13,402.75 | +679.36K% |
| November, 2030 | $13,912.02 | $13,474.47 | $13,299.36 | +695.50K% |
| December, 2030 | $14,079.33 | $13,847.68 | $13,765.93 | +703.87K% |
4.03%
2.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):